君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01877 君实生物

农历年初二休市 02-16 12:08:06

20.960

-0.460

-2.15%

最高21.020	最低20.740	成交量16.30万
今开20.940	昨收21.420	日振幅1.31%
总市值215.26亿	流通市值54.50亿	总股本10.27亿
成交额340.07万	换手率0.06%	流通股本2.60亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":20.96,"timestamp":1771214886002,"preClose":21.42,"halted":0,"volume":163000,"delay":0,"changeRate":-0.021475256769374455,"floatShares":260000000,"shares":1027000000,"eps":-1.3,"marketStatus":"农历年初二休市","change":-0.46,"latestTime":"02-16 12:08:06","open":20.94,"high":21.02,"low":20.74,"amount":3400699,"amplitude":0.013072,"askPrice":20.96,"askSize":600,"bidPrice":20.82,"bidSize":800,"shortable":3,"etf":0,"ttmEps":-1.048055,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771551000000},"marketStatusCode":7,"adr":0,"listingDate":1545580800000,"exchange":"SEHK","adjPreClose":21.42,"openAndCloseTimeList":[[1771205400000,1771214400000]],"volumeRatio":0.16244226186875232,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物","latestPrice":34.27,"timestamp":1770966000000,"preClose":34.6,"halted":0,"volume":6515600,"delay":0,"premium":"-46.09"}},"requestUrl":"/m/hq/s/01877/wiki","defaultTab":"wiki","newsList":[{"id":"2612348200","title":"每日卖空追踪 | 君实生物 02月16日卖空量成交1.9万股，卖空比例为11.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612348200","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612348200?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230622,"startTime":"0","endTime":"0","summary":"君实生物北京时间02月16日，跌2.15%，卖空量成交1.9万股，较上一交易日减少73.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163251a700de9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163251a700de9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1161","BK1583","BK1515"],"gpt_icon":0},{"id":"2611825118","title":"君实生物等在河北成立医药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2611825118","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611825118?lang=zh_cn&edition=full","pubTime":"2026-02-14 11:52","pubTimestamp":1771041155,"startTime":"0","endTime":"0","summary":"人民财讯2月14日电，企查查APP显示，近日，君华（河北）医药有限公司成立，法定代表人为童景，注册资本为2000万元，经营范围包含：生物基材料制造；生物化工产品技术研发；药品生产；药品批发；药品委托生产等。企查查股权穿透显示，该公司由君实生物旗下上海君拓生物医药科技有限公司等共同持股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602143650964879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","688180","BK1161","BK0239","BK1583","01877"],"gpt_icon":0},{"id":"2611634976","title":"每日卖空追踪 | 君实生物 02月12日卖空量成交3.64万股，卖空比例为2.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611634976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611634976?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:30","pubTimestamp":1770885026,"startTime":"0","endTime":"0","summary":"君实生物北京时间02月12日，跌2.23%，卖空量成交3.64万股，较上一交易日减少58.06%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163315a6f28b4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163315a6f28b4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1161","BK1583","BK1515"],"gpt_icon":0},{"id":"2610982090","title":"君实生物跌1.93% 2020年上市2募资共86亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610982090","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610982090?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:49","pubTimestamp":1770799778,"startTime":"0","endTime":"0","summary":"中国经济网北京2月11日讯 君实生物 今日收报35.03元，跌幅1.93%。　　上市首日，君实生物股价最高报220.40元，为上市以来股价最高点。　　君实生物首次公开发行股票募集资金总额为48.36亿元，扣除发行费用后，募集资金净额为44.97亿元，较原计划多17.97亿元。　　君实生物首次公开发行股票发行费用为3.39亿元，其中，保荐及承销费用3.20亿元。　　经计算，君实生物两次募集资金合计86.12亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260211/32012393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","01877","BK1515","688180","BK0239","BK1583"],"gpt_icon":0},{"id":"2610633641","title":"君实生物(01877)获董事长熊俊累计增持10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610633641","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610633641?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:25","pubTimestamp":1770722741,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物(01877)公布控股股东、实际控制人之一兼董事长增持股份进展，截至本公告披露日，熊俊先生通过上海证券交易所系统以集中竞价方式累计增持公司 A 股股份10万股，约占公司总股本的 0.01%，累计成交总额为人民币 383.84 万元。本次增持计划尚未实施完毕，熊俊先生将继续按照相关增持计划，在增持计划实施期间内择机增持公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403806.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","688180","BK1515","01877","BK1161","BK0239"],"gpt_icon":0},{"id":"1178068811","title":"君实生物董事长增持10万股A股，累计斥资380万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178068811","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178068811?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:19","pubTimestamp":1770722354,"startTime":"0","endTime":"0","summary":"截至2月10日，君实生物董事长通过二级市场增持公司A股股份10万股，合计交易金额达380万元人民币。此次增持体现了公司管理层对未来发展前景的信心，并向市场传递积极信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","01877","BK0239","688180","BK1583"],"gpt_icon":0},{"id":"2610969486","title":"创新药概念震荡反弹 高增长潜力概念股出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2610969486","media":"腾讯自选股综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610969486?lang=zh_cn&edition=full","pubTime":"2026-02-10 11:17","pubTimestamp":1770693474,"startTime":"0","endTime":"0","summary":"创新药概念盘中震荡反弹，广生堂涨超10%，此前万邦德涨停，尖峰集团、信立泰、北陆药业、荣昌生物、首药控股等多股涨超5%。华源证券指出，经历短期波动消化后，创新药板块已显现企稳回暖迹象。整体上，国金证券认为创新药前期回调较为充分，向上产业趋势明确，催化近期密集，继续看好板块投资机会。从未来增长潜力来看，多股获机构预测2026年净利增速有望翻倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01513","02228","06185","00867","06160","01801","BK1574","BK1515","00013","02196","01093","01276","01952","01548","02096","BK1583","02269","00512","06978","03692","01877","01177"],"gpt_icon":0},{"id":"2610694858","title":"君实生物盘中异动 早盘急速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610694858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610694858?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:49","pubTimestamp":1770691753,"startTime":"0","endTime":"0","summary":"2026年02月10日早盘10时49分，君实生物股票出现异动，股价大幅拉升5.14%。截至发稿，该股报22.900港元/股，成交量175.78万股，换手率0.68%，振幅6.43%。君实生物股票所在的生物技术行业中，整体涨幅为2.96%。其相关个股中，荣昌生物、宜明昂科-B、歌礼制药-B涨幅较大，振幅较大的相关个股有帝王国际投资、百奥赛图-B、泰格医药，振幅分别为10.91%、8.24%、8.09%。药品批发,药品委托生产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602101049139540851a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602101049139540851a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","01877","BK1583"],"gpt_icon":0},{"id":"2610268695","title":"恒生医疗保健指数升2.17%  医药板块普遍拉升 机构持续看好中国创新药出海的产业趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2610268695","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610268695?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:59","pubTimestamp":1770688793,"startTime":"0","endTime":"0","summary":"2月8日，信达生物宣布与礼来制药达成战略合作，携手推进肿瘤及免疫领域创新药物的全球研发。2026年，继续看好中国创新药出海的产业趋势，继续重点跟踪ADC、双抗、小核酸、减肥药等核心优势赛道的投资机会，期待JPM大会、ASCO等带来数据更新和BD催化。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8f73ea90e21e93e4b02cf2f8986a9c30","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","LU0196878994.USD","LU2476274720.SGD","02359","02269","LU0502904849.HKD","LU2039709279.SGD","LU1720050803.USD","BK1587","LU0634319403.HKD","IE00B5MMRT66.SGD","LU1961090484.USD","LU0359202008.SGD","06978","LU0140636845.USD","01801","LU0417516738.SGD","HK0000306701.USD","02696","09969","LU0516423174.USD","BK1161","LU0516422366.SGD","159992","LU1688375341.USD","LU2045819591.USD","09688","02268","LU2476274308.USD","LU0043850808.USD","LU0572944931.SGD","03347","159506","06990","LU0823426308.USD","159938","09995","LU1046422090.SGD","02162","01877","LU0051755006.USD","LU0856984785.SGD","LU2242644610.SGD","LU2488822045.USD","LU1969619763.USD","09926","LU0417516902.SGD","LU0348825331.USD","LU0181495838.USD","09939"],"gpt_icon":1},{"id":"2610694852","title":"每日卖空追踪 | 君实生物 02月09日卖空量成交4.38万股，卖空比例为1.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610694852","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610694852?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625825,"startTime":"0","endTime":"0","summary":"君实生物北京时间02月09日，涨4.71%，卖空量成交4.38万股，较上一交易日减少72.86%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163656a6e54eff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163656a6e54eff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","01877","BK1583"],"gpt_icon":0},{"id":"2610910016","title":"君实生物02月09日主力净流入537.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610910016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610910016?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:15","pubTimestamp":1770624958,"startTime":"0","endTime":"0","summary":"02月09日, 君实生物股价涨4.71%，报收21.78元，成交金额6810.0万元，换手率1.20%，振幅4.62%，量比1.08。君实生物今日主力资金净流入537.6万元，上一交易日主力净流出108.5万元。该股近5个交易日上涨6.24%，主力资金累计净流入1861.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1340.7万元，其中净流入天数为10日。该股主力净额占比0.09%，港股市场排名94/2715。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162458a6e5407a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162458a6e5407a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","01877","BK1515"],"gpt_icon":0},{"id":"2610186504","title":"港股异动 | 君实生物(01877)涨超5% 预期2025年度归母净亏损同比收窄31.85%左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2610186504","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610186504?lang=zh_cn&edition=full","pubTime":"2026-02-09 10:12","pubTimestamp":1770603152,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，君实生物涨超5%，截至发稿，涨4.81%，报21.8港元，成交额3991.48万港元。消息面上，近日，君实生物发布公告，预计2025年年度实现营业收入25亿元左右，同比增长28.32%左右。预计2025年年度实现归属于母公司所有者的净亏损为8.73亿左右，同比亏损减少31.85%左右。报告期内，公司营业收入增长，主要系商业化药品的销售收入与上年同期相比有所增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402989.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","01877","VT","688180","BK1161","BK4585","BK0239","BK1515","VXUS","BK4588"],"gpt_icon":0},{"id":"2608360500","title":"君实生物（688180）披露截至2026年1月31日证券变动月报，2月4日股价上涨0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608360500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608360500?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:10","pubTimestamp":1770214233,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，君实生物报收于35.41元，较前一交易日上涨0.45%，最新总市值为363.55亿元。近日，君实生物发布《截至2026年1月31日的证券变动月报》。公告显示，截至2026年1月31日，公司H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。H股于港交所上市，A股于上交所科创板上市。股份期权计划方面，H股及A股股票期权激励计划于2025年9月29日获批准采纳，本月内无新增行权或股份变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400041262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0239","688180","BK1583","BK1515","161027","01877"],"gpt_icon":0},{"id":"2608875572","title":"283只医药股披露2025年业绩预告：药明康德最能赚、创新药企业走向盈利分界线，疫苗企业业绩承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2608875572","media":"每经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608875572?lang=zh_cn&edition=full","pubTime":"2026-02-03 18:52","pubTimestamp":1770115974,"startTime":"0","endTime":"0","summary":"Wind数据显示，截至1月31日，共有283只医药股披露了2025年业绩预告。赛诺医疗预计，公司2025年归母净利润为4300万元至5000万元，同比增长2767%至3233%。此外，披露2025年度业绩预告的医药股中，药明康德预计净利润为191.51亿元，创公司上市以来的归母净利润新高。多家创新药企业预计扭亏、减亏披露业绩预告的创新药企中，不少企业出现净利扭亏、减亏的情形。此外，盟科药业、君实生物等创新药企虽未实现盈利，但已大幅减亏。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203185354a6ce4350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203185354a6ce4350&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","09995","01877","LU2242644610.SGD","LU1046422090.SGD","BK1574","LU0052750758.USD","BK1515","BK1576","LU0708995583.HKD","09939","BK1141","LU2125910500.SGD","LU2045819591.USD","02359","BK1161","09969","LU0320764599.SGD","06978"],"gpt_icon":0},{"id":"2608848840","title":"破发股君实生物连亏10年 2020年上市2募资共86亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608848840","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608848840?lang=zh_cn&edition=full","pubTime":"2026-02-03 10:44","pubTimestamp":1770086649,"startTime":"0","endTime":"0","summary":"中国经济网北京2月3日讯 君实生物 近日发布的2025年年度业绩预告显示，经财务部门初步测算，预计2025年年度实现营业收入250,000.00万元左右，与上年同期相比增长55,168.27万元左右，同比增长28.32%左右。　　上市首日，君实生物股价最高报220.40元，为上市以来股价最高点。　　君实生物首次公开发行股票发行费用为3.39亿元，其中，保荐及承销费用3.20亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260203/31993921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK0239","688180","BK1583","BK1515","01877"],"gpt_icon":0},{"id":"2608899609","title":"每日卖空追踪 | 君实生物 02月02日卖空量成交24.44万股，卖空比例为6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608899609","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608899609?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021025,"startTime":"0","endTime":"0","summary":"君实生物北京时间02月02日，跌4.12%，卖空量成交24.44万股，较上一交易日减少63.31%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163505a6c9841d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163505a6c9841d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01877","BK1161","BK1583"],"gpt_icon":0},{"id":"2608996128","title":"君实生物02月02日遭主力抛售241.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608996128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608996128?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:15","pubTimestamp":1770020150,"startTime":"0","endTime":"0","summary":"02月02日, 君实生物股价跌4.12%，报收20.50元，成交金额8404.3万元，换手率1.55%，振幅6.36%，量比0.44。君实生物今日主力资金净流出241.8万元，连续4日净流出，上一交易日主力净流出295.8万元。近一年数据显示，该股主力连续4日净流出后，次日下跌概率为60.00%，平均跌幅为4.39%。该股近5个交易日下跌13.80%，主力资金累计净流出2185.3万元；近20日主力资金累计净流出1482.6万元，其中净流出天数为13日。该股主力净额占比0.05%，港股市场排名2490/2710。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162125a4727d86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162125a4727d86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01877","BK1161","BK1583"],"gpt_icon":0},{"id":"2608899605","title":"君实生物：预计2025年年度实现营业收入约为25亿元，得益于核心产品拓益®在国内销售收入显著增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2608899605","media":"财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608899605?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:04","pubTimestamp":1770019462,"startTime":"0","endTime":"0","summary":"近日，君实生物发布公告称，预计2025年年度实现营业收入约为25亿元，与上年同期相比增长约28.32%。归母净利润预计约亏损8.73亿元，较上年亏损减少。公告指出，营业收入的增长主要得益于核心产品特瑞普利单抗注射液（拓益）在国内市场的销售收入显著增长。拓益已获批上市的12项适应症全部纳入国家医保目录，并在全球多个国家和地区获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161040a47271da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161040a47271da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877"],"gpt_icon":0},{"id":"2608678899","title":"君实生物盘中异动 大幅下跌5.05%报20.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608678899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608678899?lang=zh_cn&edition=full","pubTime":"2026-02-02 14:58","pubTimestamp":1770015481,"startTime":"0","endTime":"0","summary":"2026年02月02日下午盘14时58分，君实生物股票出现异动，股价快速下跌5.05%。截至发稿，该股报20.300港元/股，成交量344.82万股，换手率1.32%，振幅6.36%。资金方面，该股资金流入2652.43万港元，流出3278.74万港元。君实生物股票所在的生物技术行业中，整体跌幅为4.74%。其相关个股中，中生北控生物科技、嘉和生物、帝王国际投资涨幅较大，振幅较大的相关个股有瑞博生物-B、中慧生物-B、百奥赛图-B，振幅分别为15.41%、13.59%、12.17%。药品批发,药品委托生产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202145801a6c91efb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202145801a6c91efb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","01877","BK1583"],"gpt_icon":0},{"id":"2608896737","title":"荣昌生物、科兴制药、君实生物等多家创新药企2025业绩战况如何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2608896737","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608896737?lang=zh_cn&edition=full","pubTime":"2026-02-02 10:25","pubTimestamp":1769999139,"startTime":"0","endTime":"0","summary":"1月30日，包括荣昌生物、科兴制药、君实生物、百利天恒、复旦张江等多家创新药企业发布2025年业绩预告，那么2025年这些药企战绩如何？而科兴制药更是预计，2025年归母净利润同比增长328.83%至455.89%，为1.35亿元至1.75亿元。科兴制药表示，创新药管线突破奠定业绩增长基础。与荣昌生物、科兴制药的强势增长不同，百利天恒、复旦张江等则面临不同程度的业绩压力，但各有应对与布局。各家创新药企业的业绩表现，背后是2025年国产创新药行业的结构性改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104016a6c84b5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104016a6c84b5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01877","BK1574","BK1583","09995","BK1191","LU2328871848.SGD","LU1969619763.USD","06978","BK1161","01349"],"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":-0.0376},{"period":"1month","weight":-0.131},{"period":"3month","weight":-0.1417},{"period":"6month","weight":-0.3743},{"period":"1year","weight":0.6741},{"period":"ytd","weight":-0.0178}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":-0.0052},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.0612},{"period":"1year","weight":0.1806},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海君实生物医药科技股份有限公司是一家主要从事创新驱动生物制药业务的中国公司。该公司主营业务为创新药物的发现、临床研究和开发。该公司的主要产品包括特立普珠单抗注射液、依替维单抗、阿达木单抗注射液等用于治疗恶性肿瘤、自身免疫系统疾病、慢性代谢疾病、神经系统疾病和感染性疾病的药物。该公司还从事重组人源化抗PCSK9单克隆抗体注射液等药物的临床研发。该公司主要为国内外市场提供产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.098181},{"month":2,"riseRate":0.75,"avgChangeRate":0.065331},{"month":3,"riseRate":0.714286,"avgChangeRate":0.049127},{"month":4,"riseRate":0.857143,"avgChangeRate":0.101581},{"month":5,"riseRate":0.428571,"avgChangeRate":0.004505},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.018268},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.014588},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.040587},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.026161},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.004518},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043753},{"month":12,"riseRate":0.571429,"avgChangeRate":0.085319}],"exchange":"SEHK","name":"君实生物","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物,01877,君实生物股票,君实生物股票老虎,君实生物股票老虎国际,君实生物行情,君实生物股票行情,君实生物股价,君实生物股市,君实生物股票价格,君实生物股票交易,君实生物股票购买,君实生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}